0Y71 Malin Corporation Plc

TIDM0Y71

RNS Number : 2379W

Malin Corporation PLC

17 August 2022

Malin Corporation plc

Update on outstanding litigation

Dublin-Ireland, 17 August 2022: Malin Corporation plc. (Euronext Growth Dublin:MLC) ("Malin" or "the Company"), a company investing in highly innovative life sciences companies, gives this update in relation to outstanding litigation. The Company announced on 13 October 2021 that Irish High Court proceedings had been initiated by the holders of 2,803,801 A Ordinary Shares in the Company ("the Founders") against the Company claiming an entitlement to the conversion of their A Ordinary Shares into Ordinary Shares.

The Company now confirms that one of the Founders, Crow Rock Capital Limited, the holder of 787,032 A Ordinary Shares, has withdrawn its claim against Malin in those proceedings and surrendered its A Ordinary Shares to the Company.

As previously announced, the Company rejected the conversion notices previously submitted to the Company by the Founders, on the basis that no change of control has occurred and the conversion rights carried by A Ordinary Shares are not currently exercisable.

The Board will take all necessary steps to vigorously defend the Company and shareholders against the remaining Founders' claims in the proceedings.

ENDS

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com

For further information please contact:

Malin

Fiona Dunlevy, Company Secretary

Tel: +353 (0)1 901 5700

investorrelations@malinplc.com

Davy Corporate Finance (Euronext Growth Listing Sponsor & Joint Broker)

Brian Garrahy / Daragh O'Reilly

Tel: +353 1 679 6363

Liberum (Joint Broker)

Phil Walker / Ben Cryer

Tel: +44 (0) 20 3100 2000

Powerscourt (Media enquiries)

Eavan Gannon

Tel: +353 87 236 5973

malin@powerscourt-group.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCBRGDISXBDGDL

(END) Dow Jones Newswires

August 17, 2022 02:00 ET (06:00 GMT)

Malin (LSE:0Y71)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025

Malin (LSE:0Y71)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025